Springboard Capital

AxoGen, Inc. engages in the development of treatment options for the repair of peripheral nerve injuries. It offers AVANCE Nerve Graft, a human allograft nerve that is used for the repair, replacement, and reconstruction of damaged peripheral nerves. The company accepts orders through phone, fax, or email. It serves surgeons. AxoGen has a strategic tissue recovery partnership with American Tissue Services Foundation (ATSF). The company was founded in 2002 and is based in Alachua, Florida.

Consolidated Asset Recovery Systems, Inc., based in Raleigh, North Carolina, specializes in software solutions for repossession management and asset recovery. Founded in 2005 by industry veterans, the company has developed the Internet Based Electronic Asset Management (IBEAM) system, which assists banks and dealers in tracking and recovering assets. Its range of services includes repossession management, remarketing, electronic invoice payment, skip tracing, audits, legal demand letter creation, and field assistance. The company operates a vast network of recovery agents across the United States, serving lenders, dealers, and recovery agents. Since its inception, Consolidated Asset Recovery Systems has experienced significant growth and has established itself as a leader in the repossession and remarketing industry, recognized for its compliance and flexibility in adapting to clients' needs. As of 2019, it operates as a subsidiary of Primeritus Financial Services, Inc.

Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.